vs
Side-by-side financial comparison of Oportun Financial Corp (OPRT) and P3 Health Partners Inc. (PIII). Click either name above to swap in a different company.
P3 Health Partners Inc. is the larger business by last-quarter revenue ($384.8M vs $247.7M, roughly 1.6× Oportun Financial Corp). Oportun Financial Corp runs the higher net margin — 1.4% vs -19.6%, a 21.0% gap on every dollar of revenue. On growth, P3 Health Partners Inc. posted the faster year-over-year revenue change (3.8% vs -1.3%). Over the past eight quarters, P3 Health Partners Inc.'s revenue compounded faster (-0.5% CAGR vs -0.5%).
Oportun Financial Corp is a US-based fintech firm that provides accessible, responsible financial services including personal loans, credit cards, and savings products to underserved low-to-moderate income consumers, many with limited or no credit history, leveraging proprietary AI underwriting to deliver fair terms while mitigating operational risk.
P3 Health Partners Inc. is a population health management and value-based care services firm operating primarily in the United States. It partners with primary care providers and health systems to deliver coordinated, high-quality care for patient populations, especially Medicare Advantage beneficiaries, focusing on improving health outcomes and lowering unnecessary healthcare costs.
OPRT vs PIII — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $247.7M | $384.8M |
| Net Profit | $3.4M | $-75.5M |
| Gross Margin | — | — |
| Operating Margin | 2.6% | -40.0% |
| Net Margin | 1.4% | -19.6% |
| Revenue YoY | -1.3% | 3.8% |
| Net Profit YoY | -61.0% | -28.8% |
| EPS (diluted) | $0.07 | $-23.08 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $247.7M | $384.8M | ||
| Q3 25 | $238.7M | $345.3M | ||
| Q2 25 | $234.3M | $355.8M | ||
| Q1 25 | $235.9M | $373.2M | ||
| Q4 24 | $250.9M | $370.7M | ||
| Q3 24 | $250.0M | $362.1M | ||
| Q2 24 | $250.4M | $379.2M | ||
| Q1 24 | $250.5M | $388.5M |
| Q4 25 | $3.4M | $-75.5M | ||
| Q3 25 | $5.2M | $-31.6M | ||
| Q2 25 | $6.9M | $-20.4M | ||
| Q1 25 | $9.8M | $-20.5M | ||
| Q4 24 | $8.7M | $-58.6M | ||
| Q3 24 | $-30.0M | $-46.5M | ||
| Q2 24 | $-31.0M | $-12.0M | ||
| Q1 24 | $-26.4M | $-18.7M |
| Q4 25 | 2.6% | -40.0% | ||
| Q3 25 | 6.0% | -12.8% | ||
| Q2 25 | 4.3% | -9.6% | ||
| Q1 25 | 5.6% | -10.2% | ||
| Q4 24 | 89.6% | -37.4% | ||
| Q3 24 | -15.8% | -29.5% | ||
| Q2 24 | -19.6% | -8.3% | ||
| Q1 24 | -12.2% | -11.3% |
| Q4 25 | 1.4% | -19.6% | ||
| Q3 25 | 2.2% | -9.1% | ||
| Q2 25 | 2.9% | -5.7% | ||
| Q1 25 | 4.1% | -5.5% | ||
| Q4 24 | 200.1% | -15.8% | ||
| Q3 24 | -12.0% | -12.8% | ||
| Q2 24 | -12.4% | -3.2% | ||
| Q1 24 | -10.6% | -4.8% |
| Q4 25 | $0.07 | $-23.08 | ||
| Q3 25 | $0.11 | $-9.67 | ||
| Q2 25 | $0.14 | $-6.23 | ||
| Q1 25 | $0.21 | $-6.28 | ||
| Q4 24 | $0.26 | $-23.13 | ||
| Q3 24 | $-0.75 | $-15.70 | ||
| Q2 24 | $-0.78 | $-7.37 | ||
| Q1 24 | $-0.68 | $-7.86 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $105.5M | $25.0M |
| Total DebtLower is stronger | — | $228.4M |
| Stockholders' EquityBook value | $390.1M | $-155.2M |
| Total Assets | $3.3B | $656.6M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $105.5M | $25.0M | ||
| Q3 25 | $104.6M | $37.7M | ||
| Q2 25 | $96.8M | $38.6M | ||
| Q1 25 | $78.5M | $40.1M | ||
| Q4 24 | $60.0M | $38.8M | ||
| Q3 24 | $71.8M | $63.0M | ||
| Q2 24 | $72.9M | $73.1M | ||
| Q1 24 | $69.2M | $27.3M |
| Q4 25 | — | $228.4M | ||
| Q3 25 | — | $252.8M | ||
| Q2 25 | — | $182.0M | ||
| Q1 25 | — | $171.1M | ||
| Q4 24 | — | $108.9M | ||
| Q3 24 | — | $133.2M | ||
| Q2 24 | — | $133.1M | ||
| Q1 24 | — | $118.1M |
| Q4 25 | $390.1M | $-155.2M | ||
| Q3 25 | $383.9M | $-18.7M | ||
| Q2 25 | $376.0M | $44.5M | ||
| Q1 25 | $366.1M | $63.3M | ||
| Q4 24 | $353.8M | $75.9M | ||
| Q3 24 | $327.6M | $120.5M | ||
| Q2 24 | $354.1M | $166.8M | ||
| Q1 24 | $382.0M | $146.6M |
| Q4 25 | $3.3B | $656.6M | ||
| Q3 25 | $3.2B | $683.6M | ||
| Q2 25 | $3.2B | $731.6M | ||
| Q1 25 | $3.2B | $783.9M | ||
| Q4 24 | $3.2B | $783.4M | ||
| Q3 24 | $3.3B | $833.3M | ||
| Q2 24 | $3.3B | $892.8M | ||
| Q1 24 | $3.3B | $855.9M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 4.09× | ||
| Q1 25 | — | 2.71× | ||
| Q4 24 | — | 1.43× | ||
| Q3 24 | — | 1.11× | ||
| Q2 24 | — | 0.80× | ||
| Q1 24 | — | 0.81× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $413.4M | $-25.7M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | 121.45× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $413.4M | $-25.7M | ||
| Q3 25 | $99.0M | $-15.4M | ||
| Q2 25 | $104.5M | $-16.6M | ||
| Q1 25 | $101.0M | $-33.5M | ||
| Q4 24 | $393.5M | $-57.2M | ||
| Q3 24 | $108.5M | $-22.6M | ||
| Q2 24 | $107.7M | $-10.2M | ||
| Q1 24 | $85.9M | $-20.0M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.0% | ||
| Q3 24 | — | 0.0% | ||
| Q2 24 | — | 0.0% | ||
| Q1 24 | — | 0.0% |
| Q4 25 | 121.45× | — | ||
| Q3 25 | 19.05× | — | ||
| Q2 25 | 15.20× | — | ||
| Q1 25 | 10.34× | — | ||
| Q4 24 | 45.04× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
OPRT
Segment breakdown not available.
PIII
| Capitated Revenue | $366.2M | 95% |
| Health Care Patient Service | $18.6M | 5% |
| Health Care Care Coordination Management Fees | $2.7M | 1% |
